Nerveli
Nerveli is a Dallas-based digital health company that operates an AI-powered mobile platform combining CBT techniques and pain neuroscience to help individuals manage chronic pain, with dedicated modules for healthcare providers, employers, and health insurers.
- Company typePrivate
- Founded2024
- HeadquartersDallas, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What Nerveli does
Nerveli is a Dallas, Texas-based digital health company that has built a mobile platform for chronic pain management. The platform combines an AI coach trained specifically for chronic pain, pain neuroscience, and Cognitive Behavioral Therapy (CBT)-informed techniques to deliver daily tracking, pattern analysis, a guided 30-day program, and between-visit patient support. The core product is a consumer mobile app, with specialized modules extending the same platform to healthcare providers, employers, and health insurers/payors as a B2B2C offering. Underlying technology layers include structured data capture (pain, stress, sleep, activity), multimodal inputs (body maps, text), and an AI-driven recommendation and pattern-insight engine, all hosted on HIPAA-compliant infrastructure. The company monetizes through a direct-to-consumer subscription at $8.99/month or $90/year (HSA/FSA eligible), with a freemium tier launching April 2026, supplemented by enterprise licensing to providers, employers, and payors sold via direct sales with demo-based evaluation. Nerveli is a venture-backed private company founded in 2024, with $540K of pre-seed funding led by DFW Angels and a flagship strategic partnership with the American Chronic Pain Association announced in May 2026.
Nerveli firmographics
Firmographics- Name
- Nerveli
- Legal name
- Nerveli, Inc.
- Website
- https://getnerveli.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Nerveli is a Dallas-based digital health company that operates an AI-powered mobile platform combining CBT techniques and pain neuroscience to help individuals manage chronic pain, with dedicated modules for healthcare providers, employers, and health insurers.
- Ownership category
- akta.pro rank
Nerveli industry classification
Industry- Product category
- Digital Health / Chronic Pain Management Software
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ)
- akta.pro secondary industry
- Pain Management Clinics (Interventional & Medical) (HLAFABAH)
Keywords
Where Nerveli is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Nerveli business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Individual Consumer Subscription: Direct-to-consumer subscription model with monthly ($8.99/mo) and annual ($90/yr) plans. 14-day free trial available. HSA/FSA eligible. Freemium version launching April 2026.
- Enterprise/B2B Licensing: B2B licensing to employers, healthcare providers, and health insurers/payors who offer Nerveli as an employee or member benefit. Sold via direct sales with demo request process.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Monthly subscription for individual users |
| Subscription | Annual | Annual subscription - save 17% |
| Freemium | Pay-as-you-go | Freemium version |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Nerveli product offering
Product offeringCore offering
Nerveli provides an AI-powered, HIPAA-compliant mobile application for chronic pain management that combines pain and symptom tracking, an AI coach specifically trained for chronic pain, and a 30-day guided program built on Cognitive Behavioral Therapy (CBT) techniques and pain neuroscience. The platform is sold both as a direct-to-consumer subscription ($8.99/month or $90/year) and licensed to healthcare providers, employers, and health insurers as a member or employee benefit.
Product overview
Nerveli offers a single unified digital chronic pain management platform combining science-backed AI with evidence-based pain neuroscience and Cognitive Behavioral Therapy (CBT) techniques. The core Nerveli App provides individual users with pain tracking, an AI coach, and a 30-day guided program. Specialized modules extend the platform for healthcare providers (Nerveli for Providers), employers (Nerveli for Employers), and health plans/payors (Nerveli for Payors), all built on the same technology foundation and HIPAA-compliant infrastructure.
Differentiator
Problem solved
Functional benefit
Products and services
- Nerveli App A personalized, science-based chronic pain management mobile application for individual users that combines pain and symptom tracking, an AI coach trained for chronic pain, and a 30-day guided CBT-informed pain management program, designed to provide daily support between medical appointments.
- Nerveli for Providers Enterprise offering for healthcare providers and health systems that extends clinical care between visits, delivering behavioral pain management, patient progress reports, and pattern data to clinicians (pain management physicians, surgeons, physical rehabilitation specialists, and psychologists) without adding workload.
- Nerveli for Employers Enterprise employee wellness solution that gives employees access to Nerveli's evidence-based chronic pain management app, helping employers reduce missed workdays, improve retention, and increase workplace productivity among staff living with chronic pain.
- Nerveli for Payors Enterprise solution for health insurers, health plans, and payors that provides non-invasive, evidence-based chronic pain support to members to reduce unnecessary ER use, imaging, and downstream costs while improving engagement and chronic pain outcomes in value-based care models.
- 30-Day Pain Management Program Structured 30-day guided journey within the Nerveli App that delivers personalized daily support, CBT-informed pain management techniques, gamified educational tools, and science-backed education designed specifically for chronic pain relief.
Quantifiable outcome
- 74% of users reported improved understanding of their pain
- +4 more outcomes
Companies that use Nerveli
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles1 record
Nerveli technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature4 records
Nerveli partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship, minor and core.
- American Chronic Pain Association (ACPA)flagshipLandmark comprehensive strategic partnership combining Nerveli's AI-powered digital health platform with ACPA's four-decade legacy of patient-centered advocacy. Includes joint educational content development, video content series on CBT techniques, integration of up to 27,000 ACPA members into the Nerveli platform, joint grant opportunities for chronic pain research, and dedicated programming for veterans with chronic pain and mental health challenges.
- Dallas Business JournalminorRecognized as one of ten startups to watch in the Dallas-Fort Worth area, providing media coverage and visibility.
- Trinity HealthcoreNerveli is piloting with Trinity Health, a major healthcare system, for implementation of its chronic pain management platform.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
Nerveli competitors and assessment
Company assessmentDirect peers
- Curable: Curable is a direct competitor offering a chronic pain app based on mind-body medicine, CBT, and pain neuroscience education for individuals. Highly comparable in target user (chronic pain sufferers), therapeutic modality (CBT plus mind-body), and D2C-led distribution model.
- Kaia Health: Kaia Health offers a digital MSK and chronic pain app using exercise, education, and CBT, sold to payors and employers. Direct competitor in D2C + enterprise distribution of digital pain management, with overlapping AI coaching and behavioral health features.
- Hinge Health: Hinge Health is a leading digital MSK and chronic pain platform offering exercise therapy, CBT, and coaching delivered to employers and payors. Directly comparable in B2B GTM, chronic pain focus, and CBT-informed digital therapeutic modality, though at far larger scale.
- PainScale: PainScale is a chronic pain tracking and education app with provider and payor programs. Comparable in pain-focused content, tracking, and D2C-to-enterprise pipeline, though smaller scale and more limited AI coaching.
- Sword Health: Sword Health is a digital MSK and chronic pain care provider combining AI, virtual physical therapy, and behavioral support for employers and payors. Comparable in digital pain management, B2B enterprise sales motion, and AI-driven care delivery, with greater scale and capital.
Broad incumbents
- Lyra Health: Lyra Health is a mental health benefits platform sold to employers, with growing offerings in chronic pain and behavioral health. Comparable employer-facing mental wellness GTM and overlap with Nerveli's CBT-informed content and coaching, though broader in scope.
- Omada Health: Omada Health is a digital therapeutic company serving payors and employers across diabetes, hypertension, and behavioral health. Broad incumbent in the digital chronic care space with overlapping employer/payor GTM and value-based care contracting, though not a chronic pain specialist.
- Calm Health: Calm Health extends the Calm consumer mental wellness brand into chronic condition management including pain, sold to employers and health plans. Comparable in employer/payor distribution, mind-body and CBT content for pain, and large consumer brand awareness that competes for the same chronic pain users.
Emerging players
- Mahana Therapeutics: Mahana Therapeutics is a digital therapeutics company developing prescription DTx products for chronic conditions (notably IBS) with payor distribution. Comparable as a category peer in evidence-based DTx business model and payor/enterprise commercialization pathway.
- WellBrain: WellBrain is a chronic pain digital therapeutic combining CBT, mindfulness, and provider tools for health systems and payors. Comparable in chronic pain focus and CBT-informed digital care, with earlier-stage scale and similar B2B2C distribution ambitions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Nerveli social profiles
Digital presenceNerveli compliance and trust
Trust signalCompliance2 records
Nerveli financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nerveli leadership team
Management profileNumber of profiles
Profiles8 records
Nerveli funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nerveli M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nerveli
What does Nerveli do?
Nerveli provides an AI-powered, HIPAA-compliant mobile application for chronic pain management that combines pain and symptom tracking, an AI coach specifically trained for chronic pain, and a 30-day guided program built on Cognitive Behavioral Therapy (CBT) techniques and pain neuroscience. The platform is sold both as a direct-to-consumer subscription ($8.99/month or $90/year) and licensed to healthcare providers, employers, and health insurers as a member or employee benefit.
Is Nerveli a public or private company?
Nerveli is a private company. It is classified as venture growth investor backed and is currently operating.
When was Nerveli founded?
Nerveli was founded in 2024. It employs 1 to 10 people.
Where is Nerveli based?
Nerveli is headquartered in Dallas, United States, in the North America region.
How does Nerveli make money?
Two revenue lines are on record. Individual Consumer Subscription is the primary driver. The others are enterprise/B2B Licensing.
Who are Nerveli's main competitors?
Direct peers on record are Curable, Kaia Health, Hinge Health, PainScale and Sword Health. Broad incumbents are Lyra Health, Omada Health and Calm Health. Emerging players are Mahana Therapeutics and WellBrain.
Does Nerveli have an API?
No public API is recorded for Nerveli.
What industry is Nerveli in?
Nerveli's product category is Digital Health / Chronic Pain Management Software. Its primary akta.pro industry code is HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics, with a secondary code of HLAFABAH, Pain Management Clinics (Interventional & Medical). Its NAICS code is 62134 and its SIC code is 3845.